Remifentanil, an esterase metabolised opioid: What advantages does it offer in analgesia and anaesthesia?

CNS Drugs

Volumn 8, Issue 3, 1997, Pages 189-198

  Lauwers, Marylin ^a   Camu, Frederic ^a   Vanlersberghe, Caroline ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

REMIFENTANIL;

ANALGESIA; ANESTHESIA; ARTICLE; BRADYCARDIA; DRUG METABOLISM; HUMAN; HYDROLYSIS; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE RIGIDITY; PHARMACODYNAMICS; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; VOMITING;

EID: 0030772716     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199708030-00001     Document Type: Article

References (34)

1. Mangano DT, Hollenherg M, Fegert G. et al. Perioperative myocardial ischemia in patients undergoing non-cardiac surgery. I. Incidence and severity during the tour day perioperative period. J Am Coll Cardiol 1991; 17: 843-50
2. James MK, Feldman PL, Schuster SV, et al. Opioid receptor activity of G181084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259(2): 712-8
3. Glass PSA, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (G187084B). Anesth Analg 1993; 77: 1031-40
4. Egan TD, Lemmens HJM, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (G187084B) in healthy adult male volunteers. Anesthesiology 1993; 79: 881-92
5. Egan TD, Minto CF, Hermann DJ, et al. Remifentanil versus alfentanil. Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-33
6. Crabb I, Thornton C, Konieczko KM, et al. Remifentanil reduces auditory and somatosensory evoked responses during isoflurane anaesthesia in a dose-dependent manner. Br J Anaesth 1996; 76: 795-801
7. Kapila A, Glass PSA, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995; 83(5): 968-75
8. Amin HM, Sopchak AM, Esposito BF, et al. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil and alfentanil. J Pharmacol Exp Ther 1995; 274 (1): 34-9
9. Westmorland CJ, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (G187084B) and its major metabolite (G190291) in patients undergoing elective inpatient surgery. Anesthesiology 1993; 79: 893-903
10. Egan TD, Billard V, Barr J, et al. Gender has no effect on the pharmacokinetics or pharmacodynamics of remifentanil [abstract]. Anesthesiology 1995; 83: A325
11. Minto CF, Schnider TW, Egan TD, et al. The influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. 1: model development. Anesthesiology 1997; 86: 10-23
12. Duthie DJR, Muir KT, Baddoo HHK, et al. Remifentanil is not metabolized by the lung [abstract]. Anesthesiolocy 1995; 83: A324
13. Selinger K, Nation RL, Smith GA, Enzymatic and chemical hydrolysis of remifentanil [abstract]. Anesthesiology 1995: 83: A385
14. Cunningham FE, Hoke JF, Muir KT, et al. Pharmacokinetic/ pharmacodynamic evaluation of remifentanil. GR90291 and alfentanil [abstract]. Anesthesiology 1995; 83: A376
15. Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84: 812-20
16. Bowdle TA, Camporesi EM, Maysick L, et al. A multicenter evaluation of remifentanil for early postoperative analgesia. Anesth Analg 1996; 83: 1292-7
17. Michelsen LG, Salmenperä M, Hug CC, et al. Anesthetic potency of remifentanil in dogs. Anesthesiology 1996; 84: 865-72
18. Joshi P, Jhaveri R, Bauman V, et al. Comparative trial of remifentanil and alfentanil for anesthesia induction [abstract]. Anesthesiology 1993; 79: A379
19. Kovac A, Azad S, Batenhorst R, et al. Remifentanil versus alfentanil balanced anesthesia for total abdominal hysterectomy [abstract]. Anesthesiology 1995; 83: A383
20. Kallar SK, Hurt TW, Wetchler BV, et al. A single-blind, comparative study of the safety and efficacy of remifentanil and alfentanil for outpatient anesthesia [abstract]. Anesthesiology 1994; 81: A32
21. Hogue CW, Bowdle TA, OLeary C, et al. A multicenler evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatienl surgery. Anesth Analg 1996; 83: 279-85
22. Fragen RJ, Randel GI, Librojo ES, et al. The interaction of remifentanil and propofol to prevent response lo tracheal intubation and the start of surgery for outpatient knee arthroscopy [abstract]. Anesthesiology 1994; 81: A376
23. Philip BK, Scuderi PE, Chung F, et al. Remifentanil compared with alfentanil for ambulatory surgery using total intravenous anesthesia. Anesth Analg 1997; 84: 515-21
24. Sebel PS, Hoke JF, Westmoreland C, et al. Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 1995; 80: 990-3
25. Dershwitz M, Randel GI, Rosow CE, et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995; 81: 619-23
26. Munday IT, Ward PM, Sorooshian S, et al. Interaction between remifentanil and isoflurane in spontaneously breathing patients during ambulatory surgery [abstract]. Anesthesiology 1995; 83: A23
27. Lang E, Kapila A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996; 85: 721-8
28. Schlugman D, Dufore S, Dershwitz M, et al. Respiratory effects of remifentanil in subjects with severe renal impairment compared to matched controls [abstract]. Anesthesiology 1994; 81: A1417
29. Minto CF, Schnider TW, Shafer SL. The pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997; 86: 24-33
30. Davis PJ, Ross A, Stiller RL, et al. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age [abstract]. Anesth Analg 1995; 80: S93
31. Roystin D, Renifentail in cardiac surgery. Eur J Anaesthesiol 1995; 12 Suppl. 10: 77-9
32. Warner DS, Hindman BJ, Todd MM, et al. Intracranial pressure and hemodynamic effecls ot remifentanil versus alfentanil in patients undergoing supratentorial craniotomy. Anesth Analg 1996; 83: 348-53
33. Camu F, Breivik H, Hagelberg A, et al. A double-blind placebo controlled study of the safety and efficacy of remifentanil used as an adjunct sedative in patients receiving regional anesthesia [abstract]. Anesthesiology 1995; 83: A847
34. Desmonts JM, Aitkenhead AR, Camu F, et al. Comparison of remifentanil and propofol as adjunct therapy during regional anesthesia [abstract]. Anesthesiology 1995; 83: A857